Sep. 18, 2021

TAK-418

brain-penetrant LSD1 inh. for neuro. disorders sociability improvement in vivo, completed Ph. I in HV tranylcypromine class mechanism-based inh. Sci. Adv., Mar. 12, 2021 Takeda Pharmaceuticals, Fujisawa, JP

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in